Sacro-B
En vente sur le marché américain (selon le DSLD)
Thorne, food supplement from the US market
Sacro-B (Thorne), a food supplement au code-barres 693749757030, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Thorne
- Barcode
- 693749757030
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 3 servings per day
- Other ingredients (in English, as written)
- Hydroxypropyl Methylcellulose, Pectin, Water, Beet Fiber, Calcium Laurate, Medium Chain Triglycerides
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Saccharomyces boulardii CNCM I-3799 | Other substance | 250 mg |
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Sacro-B
Entered into DSLD on 22 August 2025. Retirée du marché américain le 17 June 2025 (selon le DSLD).Same active composition.
Official label: Sacro-B
Entered into DSLD on 25 March 2025. En vente sur le marché américain (selon le DSLD).- Same quantity, different name: Saccharomyces boulardii in this version; Saccharomyces boulardii CNCM I-3799 on the displayed label (250 mg)
Official label: Sacro-B
Entered into DSLD on 22 February 2024. En vente sur le marché américain (selon le DSLD).- Same quantity, different name: Saccharomyces boulardii in this version; Saccharomyces boulardii CNCM I-3799 on the displayed label (250 mg)
Official label: Sacro-B
Entered into DSLD on 16 June 2022. Retirée du marché américain le 21 July 2023 (selon le DSLD).- Same quantity, different name: Saccharomyces boulardii in this version; Saccharomyces boulardii CNCM I-3799 on the displayed label (250 mg)
Official label: Sacro-B
Entered into DSLD on 22 October 2021. Retirée du marché américain le 1 December 2021 (selon le DSLD).- Same quantity, different name: Saccharomyces boulardii in this version; Saccharomyces boulardii CNCM I-3799 on the displayed label (250 mg)
Official label: Sacro-B
Entered into DSLD on 24 June 2019. Retirée du marché américain le 4 October 2021 (selon le DSLD).- Same quantity, different name: Saccharomyces boulardii in this version; Saccharomyces boulardii CNCM I-3799 on the displayed label (250 mg)
Official label: Sacro-B
Entered into DSLD on 25 October 2018. Retirée du marché américain le 26 November 2018 (selon le DSLD).- Same quantity, different name: Saccharomyces boulardii in this version; Saccharomyces boulardii CNCM I-3799 on the displayed label (250 mg)
Official label: Sacro-B
Entered into DSLD on 23 June 2017. Retirée du marché américain le 19 December 2017 (selon le DSLD).- Same quantity, different name: Saccharomyces boulardii in this version; Saccharomyces boulardii CNCM I-3799 on the displayed label (250 mg)
Official label: Sacro-B
Entered into DSLD on 23 June 2017. Retirée du marché américain le 16 February 2017 (selon le DSLD).- Same quantity, different name: Saccharomyces boulardii in this version; Saccharomyces boulardii CNCM I-3799 on the displayed label (250 mg)
Official label: Sacro-B
Entered into DSLD on 25 September 2015. Retirée du marché américain le 3 November 2016 (selon le DSLD).- Same quantity, different name: Saccharomyces boulardii in this version; Saccharomyces boulardii CNCM I-3799 on the displayed label (250 mg)
Older versions (3)
Official label: Sacro-B
Entered into DSLD on 25 June 2015. Retirée du marché américain le 5 August 2015 (selon le DSLD).- Same quantity, different name: Saccharomyces boulardii in this version; Saccharomyces boulardii CNCM I-3799 on the displayed label (250 mg)
Official label: Sacro-B
Entered into DSLD on 25 June 2013. Retirée du marché américain le 27 March 2015 (selon le DSLD).- Same quantity, different name: Saccharomyces boulardii in this version; Saccharomyces boulardii CNCM I-3799 on the displayed label (250 mg)
Official label: Sacro-B
Entered into DSLD on 21 December 2012. Retirée du marché américain le 1 April 2013 (selon le DSLD).- Same quantity, different name: Saccharomyces boulardii in this version; Saccharomyces boulardii CNCM I-3799 on the displayed label (250 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : Thorne
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.